Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20221 AL 20235

Neuroprotective Herbs Associated with Parkinson's and Alzheimer's Disease

Marțiș GS, Ungur RA, Pop A, Bordean EM, Pașca C, Borda IM.

Nutrients. 2026 Jan 29;18(3):439. doi: 10.3390/nu18030439.

Current potential biomarkers for Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: review of literature

Peng J, Fan T, Wang J, Deng Y, Xu R.

Dialogues Clin Neurosci. 2026 Dec;28(1):17-39. doi: 10.1080/19585969.2026.2622722. Epub 2026 Feb 6.

[Speech signal acoustic analysis in the diagnosis of neurological and mental diseases: a systematic review and meta-analysis]

Garanin AA, Aydumova OY, Rubanenko AO, Khumorova AR, Kolsanov AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(3):38-44. doi: 10.17116/jnevro202612603138.

The effect of GLP-1 receptor agonists on autophagy: insights gathered from research evaluating neurodegenerative disorders with these agents

Sioufi MC, Heroiu I, Wong S, Le GH, Dri CE, Zheng YJ, Teopiz KM, Rhee TG, Lo HKY, Guillen-Burgos HF, McIntyre RS.

Acta Neuropsychiatr. 2026 Feb 13;38:e24. doi: 10.1017/neu.2026.10060.

Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease

Tropea TF, Stevenson PA, Flitter M, Meehan D, Morris A, Lu M, Iaccarino L, Collins EC, Hodsdon ME, Irwin D, Spindler M, Deik A, Dahodwala N, Cousins KAQ, Wolk DA, Shaw L, Weintraub D, Lee EB, Chen-Plotkin A, Mintun M, Siderowf A.

Ann Neurol. 2026 Jun;99(6):1428-1437. doi: 10.1002/ana.78201. Epub 2026 Mar 18.

[Myoclonus in Alzheimer's disease]

Bogolepova AN, Burd SG, Lebedeva AV, Rubleva YV, Kovalenko EA, Machnovich EV, Osinovskaya NA, Pantina NV, Kovaleva II, Bokitko TA, Alexeeva GA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4. Vyp. 2):63-69. doi: 10.17116/jnevro202612604263.

Differential effects of PSEN1 mutations (p.P117L with ataxia and p.P264L without ataxia) in early-onset Alzheimer's disease

Gao P, Chen B, Xu D, Wang Q, Yang M, Lin G, Zhou H, Huang X, Zeng Y, Liang S, Li J, Liu Q, Yao K, Xiao Z, Zhong X, Ning Y.

J Alzheimers Dis. 2026 May;111(1):132-141. doi: 10.1177/13872877261430771. Epub 2026 Mar 16.

Predictors for survival in patients with Alzheimer's disease: a large comprehensive meta-analysis

Zheng X, Wang S, Huang J, Li C, Shang H.

Transl Psychiatry. 2024 Apr 10;14(1):184. doi: 10.1038/s41398-024-02897-w.

Sleep characteristics and risk of Alzheimer's disease: a systematic review and meta-analysis of longitudinal studies

Wang S, Zheng X, Huang J, Liu J, Li C, Shang H.

J Neurol. 2024 Jul;271(7):3782-3793. doi: 10.1007/s00415-024-12380-7. Epub 2024 Apr 24.

[Networkmodulation through deep brain stimulation]

Visser-Vandewalle V.

Tijdschr Psychiatr. 2023;65(10):619-623.

Neuroimaging in Dementia

Risacher SL, Apostolova LG.

Continuum (Minneap Minn). 2023 Feb 1;29(1):219-254. doi: 10.1212/CON.0000000000001248.

Bibliometric review on sleep and Alzheimer disease between 1986 and 2023

Sun X, He C, Qu H.

Medicine (Baltimore). 2023 Nov 3;102(44):e35764. doi: 10.1097/MD.0000000000035764.

Depression in dementia with Lewy bodies: a critical update

Jellinger KA.

J Neural Transm (Vienna). 2023 Oct;130(10):1207-1218. doi: 10.1007/s00702-023-02669-8. Epub 2023 Jul 7.

The Rare Marine Bioactive Compounds in Neurological Disorders and Diseases: Is the Blood-Brain Barrier an Obstacle or a Target?

Diao X, Han H, Li B, Guo Z, Fu J, Wu W.

Mar Drugs. 2023 Jul 18;21(7):406. doi: 10.3390/md21070406.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias